| Dr Mark Vincent Guido, MD, | |
|
755 Highland Oaks Dr Ste 201, Winston Salem, NC 27103 | |
| (336) 765-0020 | |
| Not Available |
| Full Name | Dr Mark Vincent Guido |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 11 Years |
| Location | 755 Highland Oaks Dr Ste 201, Winston Salem, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740627496 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Forsyth Medical Center | Winston-salem, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Forsyth Memorial Hospital Inc | 9537071790 | 531 |
News Archive
Sirnaomics, Inc. announced today that the company has cemented a partnership with a Chinese pharmaceutical company for development of its small interfering RNA (siRNA) therapeutic (STP705) for scarless wound healing.
Micromet, Inc. announced today that it has entered into a collaboration agreement with Amgen Inc. for the research of BiTE antibodies against three undisclosed solid tumor targets.
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and have to undergo surgery plus chemotherapy. During the operation, surgeons attempt to remove all tumor deposits as this leads to improved patient prognosis. To do this, however, they primarily have to rely on visual inspection and palpation - an enormous challenge especially in the case of small tumor nests or remaining tumor borders after the primary tumor excision.
Using data from government agencies and private watchdogs, several websites provide consumer information on hospitals.
› Verified 6 days ago
| Entity Name | Forsyth Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104548874 PECOS PAC ID: 9537071790 Enrollment ID: O20040405001702 |
News Archive
Sirnaomics, Inc. announced today that the company has cemented a partnership with a Chinese pharmaceutical company for development of its small interfering RNA (siRNA) therapeutic (STP705) for scarless wound healing.
Micromet, Inc. announced today that it has entered into a collaboration agreement with Amgen Inc. for the research of BiTE antibodies against three undisclosed solid tumor targets.
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and have to undergo surgery plus chemotherapy. During the operation, surgeons attempt to remove all tumor deposits as this leads to improved patient prognosis. To do this, however, they primarily have to rely on visual inspection and palpation - an enormous challenge especially in the case of small tumor nests or remaining tumor borders after the primary tumor excision.
Using data from government agencies and private watchdogs, several websites provide consumer information on hospitals.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Vincent Guido, MD, Po Box 60447, Charlotte, NC 28260-0447 Ph: (704) 384-0567 | Dr Mark Vincent Guido, MD, 755 Highland Oaks Dr Ste 201, Winston Salem, NC 27103 Ph: (336) 765-0020 |
News Archive
Sirnaomics, Inc. announced today that the company has cemented a partnership with a Chinese pharmaceutical company for development of its small interfering RNA (siRNA) therapeutic (STP705) for scarless wound healing.
Micromet, Inc. announced today that it has entered into a collaboration agreement with Amgen Inc. for the research of BiTE antibodies against three undisclosed solid tumor targets.
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and have to undergo surgery plus chemotherapy. During the operation, surgeons attempt to remove all tumor deposits as this leads to improved patient prognosis. To do this, however, they primarily have to rely on visual inspection and palpation - an enormous challenge especially in the case of small tumor nests or remaining tumor borders after the primary tumor excision.
Using data from government agencies and private watchdogs, several websites provide consumer information on hospitals.
› Verified 6 days ago
Shannon Mitchell St Clair, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 186 Kimel Park Dr, Winston Salem, NC 27103 Phone: 336-277-2000 Fax: 336-277-2050 | |
Dr. Kamal Hanee Henderson, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 186 Kimel Park Dr, Winston Salem, NC 27103 Phone: 336-277-2000 Fax: 336-277-2050 | |
Dr. Michael Joseph Mccormack Jr., M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Medical Center Blvd, Winston Salem, NC 27157 Phone: 336-716-2255 | |
Brooke Williams, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3333 Silas Creek Pkwy, Winston Salem, NC 27103 Phone: 336-718-8383 | |
Dr. David Defeo, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3001 Lyndhurst Ave, Winston Salem, NC 27103 Phone: 336-765-0383 Fax: 336-768-1737 | |
James Alan Senft, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Medical Center Blvd, Winston Salem, NC 27157 Phone: 336-716-2011 Fax: 336-713-9576 | |
Dr. Michael Richard Morgan, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1381 Westgate Center Dr, Winston Salem, NC 27103 Phone: 336-718-7080 Fax: 336-718-0441 |